Group B Meningococcal Disease on Campus Again

Abstract

In the U.S., Neisseria meningitidis serogroup B (MenB) is responsible for about half of all cases of invasive meningococcal disease in people aged 17 to 22. Recently, two MenB vaccines were licensed for use in this country. On February 2, 2015, a case of MenB disease was reported in a male student attending Providence College. Three days later, …